News & Press Releases

Bridge to Life Ltd. announced today its divestiture of certain assets to TransMedics, Inc., a wholly owned subsidiary of TransMedics Group, Inc., including its EVOSS heart and lung and LifeCradle heart perfusion assets.

Bridge to Life Ltd. announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress (ATC).

Bridge to Life, Ltd. announced that it met positive criteria from interim analysis for early enrollment closure of its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial.

Bridge to Life, Ltd. announced the expansion of their executive leadership team by appointing Bob Beechey as Chief Financial Officer and Blago Herrera as Vice President of Operations.

Bridge to Life, Ltd. announced early results from its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial.

Steve Schweighardt, founder and former CEO to retire from daily operations but will remain as Chairman of the Board.

Bridge to Life advances their perfusion system development with the breakthrough device designation for the LifeCradle® Heart Preservation Transport system.

Bridge to Life Ltd. announced first enrollment and orthotopic liver transplantation in its U.S. pivotal Bridge to HOPE Liver Clinical Trial.

Drew David, a teenager from South Carolina, and Dr. Randy Giles, a surgeon from New Jersey, will be two of 44 organ donors honored on the annual Donate Life Rose Parade Float this January.

Bridge to Life, Ltd. announced investigational device exemption approval by the U.S. FDA for its VitaSmart™ Liver Machine Perfusion System and plans to enroll the first patient in its U.S. Bridge to HOPE Liver Clinical Trial by the end of 2021.

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, announced the first closing of a growth financing, totaling $56 million, led by Perceptive Advisors, a leading life sciences investment firm.

Bridge to Life Chairman & CEO Stevan Schweighardt was interviewed in a feature piece for CEOCFO Magazine. He discusses the challenges of the transplant field and Bridge to Life’s current and upcoming solutions to make organ transplantations more successful.

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, and Tevosol, Inc., a clinical stage medical device startup, today announced their merger to develop and commercialize groundbreaking new products for the organ transplantation community. The arrangement includes Bridge to Life’s significant financial commitment to manufacture, trial, and launch Tevosol’s portable ex-vivo lung perfusion (EVLP) machine and normothermic organ preservation platform.

Bridge to Life is proud to have sponsored two webinars in the ILTS Insights series. Each webinar can be watched below.

A teenager from South Carolina and surgeon from New Jersey will be two of 44 organ donors honored on the annual Donate Life Rose Parade Float this January. Drew David and Dr. Randy Giles will each be memorialized with a floragraph, an artistic floral portrait. The floragraphs were made possible by We Are Sharing Hope SC, Donate Life South Carolina, and New Jersey Sharing Network, with sponsorship from Bridge to Life.

Donate Life and the South Carolina Department of Motor Vehicles held an event on April 16th at the South Carolina State House marking the 10th anniversary of Donate Life and spreading awareness of April as Donate Life Month.

A teenager from South Carolina and surgeon from New Jersey will be two of 44 organ donors honored on the annual Donate Life Rose Parade Float this January. Drew David and Dr. Randy Giles will each be memorialized with a floragraph, an artistic floral portrait. The floragraphs were made possible by We Are Sharing Hope SC, Donate Life South Carolina, and New Jersey Sharing Network, with sponsorship from Bridge to Life.

A smartphone app designed to draw the interest of younger people was developed by the Kentucky Organ Donor Affiliates (KODA) with funding from a Bridge to Life grant. The app, named “Bridge2Life”, attempts to meet the challenge of growing the donation registry in an age when younger people no longer obtain driver’s licenses so readily and tend to consult social media for information about life’s issues. The app has been widely applauded in its nation-wide tour promoting Growing the Registry, most recently by winning the AATB Groundbreaker Award in Dallas, Oct 12.